Disse bivirkninger er dog tidligere set som følge af behandling med cisplatin- monoterapi og skyldes ikke topotecan.
Additional adverse events were seen when topotecan was given in combination with cisplatin, however, these events were seen with cisplatin monotherapy and not attributable to topotecan.